David K. Shay
#148,278
Most Influential Person Now
Researcher
David K. Shay's AcademicInfluence.com Rankings
David K. Shayengineering Degrees
Engineering
#5881
World Rank
#7168
Historical Rank
Electrical Engineering
#1688
World Rank
#1786
Historical Rank
David K. Shaycomputer-science Degrees
Computer Science
#7609
World Rank
#8010
Historical Rank
Computational Linguistics
#1547
World Rank
#1564
Historical Rank
Machine Learning
#2861
World Rank
#2896
Historical Rank
Artificial Intelligence
#3154
World Rank
#3200
Historical Rank
Download Badge
Engineering Computer Science
David K. Shay's Degrees
- PhD Computer Science Stanford University
- Masters Electrical Engineering University of California, Berkeley
- Bachelors Computer Engineering University of California, Berkeley
Similar Degrees You Can Earn
Why Is David K. Shay Influential?
(Suggest an Edit or Addition)David K. Shay's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- MORTALITY ASSOCIATED WITH INFLUENZA AND RESPIRATORY SYNCYTIAL VIRUS IN THE UNITED STATES (2002) (3656)
- Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). (2006) (2456)
- Influenza-associated hospitalizations in the United States. (2004) (2179)
- Bronchiolitis-associated hospitalizations among US children, 1980-1996. (1999) (1427)
- Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. (2012) (1156)
- Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. (2009) (1047)
- Influenza and the rates of hospitalization for respiratory disease among infants and young children. (2000) (1035)
- Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP). (2011) (780)
- Estimates of deaths associated with seasonal influenza --- United States, 1976-2007. (2010) (764)
- Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. (2006) (672)
- Influenza-associated deaths among children in the United States, 2003-2004. (2005) (637)
- Effectiveness of pneumococcal polysaccharide vaccine in older adults. (2003) (633)
- Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. (2010) (544)
- Enterococci Resistant to Multiple Antimicrobial Agents, Including Vancomycin: Establishment of Endemicity in a University Medical Center (1995) (505)
- Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. (2012) (501)
- Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997. (2001) (488)
- Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988-2002. (2005) (431)
- The Burden of Community-Acquired Pneumonia in Seniors: Results of a Population-Based Study (2004) (413)
- Estimates of US influenza‐associated deaths made using four different methods (2009) (353)
- Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices--United States, 2013-2014. (2013) (341)
- Mask use, hand hygiene, and seasonal influenza-like illness among young adults: a randomized intervention trial. (2010) (335)
- Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections. (1995) (327)
- Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. (2014) (322)
- Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. (2008) (317)
- Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. (2009) (306)
- Incidence of outpatient visits and hospitalizations related to influenza in infants and young children. (2004) (280)
- Epidemiology of seasonal influenza: use of surveillance data and statistical models to estimate the burden of disease. (2006) (277)
- Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021. (2022) (274)
- The case test-negative design for studies of the effectiveness of influenza vaccine. (2013) (253)
- Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. (2012) (246)
- Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. (2007) (246)
- Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. (2007) (227)
- Influenza- and RSV-associated hospitalizations among adults. (2007) (224)
- Influenza-Associated Pediatric Mortality in the United States: Increase of Staphylococcus aureus Coinfection (2008) (213)
- Prevalence of low birth weight among Hispanic infants with United States-born and foreign-born mothers: the effect of urban poverty. (1994) (201)
- Effectiveness of influenza vaccine during pregnancy in preventing hospitalizations and outpatient visits for respiratory illness in pregnant women and their infants. (2004) (200)
- Infection-Control Measures Reduce Transmission of Vancomycin-Resistant Enterococci in an Endemic Setting (1999) (197)
- Influenza Illness and Hospitalizations Averted by Influenza Vaccination in the United States, 2005–2011 (2013) (186)
- Risk factors for bronchiolitis-associated deaths among infants in the United States (2003) (185)
- Prenatal and Infant Exposure to Thimerosal From Vaccines and Immunoglobulins and Risk of Autism (2010) (185)
- Influenza vaccine effectiveness in the community and the household. (2013) (180)
- Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children. (2006) (180)
- Bronchiolitis management preferences and the influence of pulse oximetry and respiratory rate on the decision to admit. (2003) (175)
- The safety of newborn early discharge. The Washington State experience. (1997) (161)
- Early Estimates of Seasonal Influenza Vaccine Effectiveness — United States, January 2013 (2013) (161)
- Evaluation of self-reported and registry-based influenza vaccination status in a Wisconsin cohort. (2009) (155)
- Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis. (2015) (153)
- Monitoring Influenza Activity in the United States: A Comparison of Traditional Surveillance Systems with Google Flu Trends (2011) (153)
- Active Surveillance of Vaccine Safety: A System to Detect Early Signs of Adverse Events (2005) (150)
- Estimating influenza-associated deaths in the United States. (2009) (149)
- Clinical characteristics and 30-day outcomes for influenza A 2009 (H1N1), 2008-2009 (H1N1), and 2007-2008 (H3N2) infections. (2010) (148)
- Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. (2007) (148)
- Multistate Surveillance for Laboratory-Confirmed, Influenza-Associated Hospitalizations in Children: 2003–2004 (2006) (145)
- Effectiveness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: a population-based case-control study during the 2010-2011 and 2011-2012 influenza seasons. (2014) (141)
- An outbreak of cryptosporidiosis linked to a foodhandler. (2000) (141)
- Human parainfluenza virus-associated hospitalizations among children less than five years of age in the United States (2001) (138)
- Unraveling R0: Considerations for Public Health Applications (2014) (134)
- Influenza-associated mortality in temperate and subtropical Chinese cities, 2003-2008. (2012) (132)
- Innate Immune Function and Mortality in Critically Ill Children With Influenza: A Multicenter Study* (2013) (128)
- Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old. (2006) (126)
- Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine — United States, March–April 2021 (2021) (122)
- Perinatal Risk Factors for Infant Hospitalization With Viral Gastroenteritis (1999) (121)
- Immunosenescence and Challenges of Vaccination against Influenza in the Aging Population. (2012) (121)
- Effectiveness of Non-Adjuvanted Pandemic Influenza A Vaccines for Preventing Pandemic Influenza Acute Respiratory Illness Visits in 4 U.S. Communities (2011) (116)
- Impact of maternal influenza vaccination during pregnancy on the incidence of acute respiratory illness visits among infants. (2006) (115)
- Mortality from pneumonia in children in the United States, 1939 through 1996. (2000) (110)
- Bronchiolitis-associated hospitalizations among American Indian and Alaska Native children. (2000) (108)
- Effectiveness of Interventions to Reduce Contact Rates during a Simulated Influenza Pandemic (2007) (105)
- Influenza circulation and the burden of invasive pneumococcal pneumonia during a non-pandemic period in the United States. (2009) (103)
- Immunogenicity of varying dosages of 7-valent pneumococcal polysaccharide-protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine. (2007) (102)
- Risk factors for Nipah virus infection among abattoir workers in Singapore. (2000) (101)
- Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries in Preventing Postinfluenza Deaths During 2012–2013 and 2013–2014 (2017) (96)
- COVID-19 Vaccine Safety in Adolescents Aged 12–17 Years — United States, December 14, 2020–July 16, 2021 (2021) (96)
- Bloodstream infections with vancomycin-resistant enterococci. (1996) (94)
- Comparison of clinical features and outcomes of medically attended influenza A and influenza B in a defined population over four seasons: 2004–2005 through 2007–2008 (2011) (94)
- COVID-19 Vaccine Safety in Children Aged 5-11 Years - United States, November 3-December 19, 2021. (2021) (94)
- Influenza vaccine effectiveness in Wisconsin during the 2007-08 season: comparison of interim and final results. (2011) (90)
- Studies Needed to Address Public Health Challenges of the 2009 H1N1 Influenza Pandemic: Insights from Modeling (2010) (88)
- Bloodstream infections in home infusion patients: the influence of race and needleless intravascular access devices. (1996) (88)
- Costs and Savings Associated With Infection Control Measures That Reduced Transmission of Vancomycin-Resistant Enterococci in an Endemic Setting (2001) (87)
- Household Responses to School Closure Resulting from Outbreak of Influenza B, North Carolina (2008) (85)
- Association between obesity and vulnerability and serologic response to influenza vaccination in older adults. (2012) (85)
- Development and estimation of a pediatric chronic disease score using automated pharmacy data. (1999) (83)
- Myocarditis Occurring After Immunization With mRNA-Based COVID-19 Vaccines. (2021) (83)
- Effectiveness of 2008-09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1) - United States, May-June 2009. (2009) (82)
- Deaths averted by influenza vaccination in the U.S. during the seasons 2005/06 through 2013/14☆ (2015) (75)
- Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe (2022) (68)
- Outpatient and hospital visits associated with otitis media among American Indian and Alaska native children younger than 5 years. (2002) (67)
- The Burden of Influenza-Associated Critical Illness Hospitalizations* (2014) (62)
- An Outbreak of Acute Gastroenteritis in a Geriatric Long-Term–Care Facility: Combined Application of Epidemiological and Molecular Diagnostic Methods (1999) (58)
- Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination — PCORnet, United States, January 2021–January 2022 (2022) (58)
- Unraveling R0: considerations for public health applications. (2014) (58)
- Case Series of Thrombosis With Thrombocytopenia Syndrome After COVID-19 Vaccination—United States, December 2020 to August 2021 (2022) (57)
- COVID-19 Vaccination and Non–COVID-19 Mortality Risk — Seven Integrated Health Care Organizations, United States, December 14, 2020–July 31, 2021 (2021) (56)
- Safety Monitoring of an Additional Dose of COVID-19 Vaccine — United States, August 12–September 19, 2021 (2021) (55)
- Comparison of Nasal and Nasopharyngeal Swabs for Influenza Detection in Adults (2012) (53)
- Epidemiology of pandemic influenza: use of surveillance and modeling for pandemic preparedness. (2006) (52)
- Eczematous Skin Disease and Recall of Past Diagnoses: Implications for Smallpox Vaccination (2003) (51)
- Safety of varying dosages of 7-valent pneumococcal protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine. (2005) (47)
- Anxiety-Related Adverse Event Clusters After Janssen COVID-19 Vaccination — Five U.S. Mass Vaccination Sites, April 2021 (2021) (46)
- Regional variation in mortality impact of the 2009 A(H1N1) influenza pandemic in China (2013) (45)
- Asthma and bronchiolitis hospitalizations among American Indian children. (2000) (44)
- A large, population-based study of 2009 pandemic Influenza A virus subtype H1N1 infection diagnosis during pregnancy and outcomes for mothers and neonates. (2012) (43)
- Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices — United States, December 2021 (2022) (43)
- The expected emotional benefits of influenza vaccination strongly affect pre-season intentions and subsequent vaccination among healthcare personnel. (2012) (41)
- Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults — United States, September 22, 2021–February 6, 2022 (2022) (40)
- Effectiveness of Inactivated Influenza Vaccines in Preventing Influenza-Associated Deaths and Hospitalizations among Ontario Residents Aged ≥65 Years: Estimates with Generalized Linear Models Accounting for Healthy Vaccinee Effects (2013) (40)
- Influenza and malaria coinfection among young children in western Kenya, 2009-2011. (2012) (39)
- Population-based incidence estimates of influenza-associated respiratory failure hospitalizations, 2003 to 2009. (2013) (38)
- Influenza-Related Hospitalization and ED Visits in Children Less Than 5 Years: 2000–2011 (2015) (38)
- Magnitude of potential biases in a simulated case-control study of the effectiveness of influenza vaccination. (2012) (37)
- Further Evidence for Bias in Observational Studies of Influenza Vaccine Effectiveness: The 2009 Influenza A(H1N1) Pandemic (2013) (37)
- Attitudes of healthcare workers in U.S. hospitals regarding smallpox vaccination (2003) (36)
- Vitamin D is not associated with serologic response to influenza vaccine in adults over 50 years old. (2013) (36)
- Effect of the 2009 influenza A(H1N1) pandemic on invasive pneumococcal pneumonia. (2013) (36)
- A probability model for evaluating the bias and precision of influenza vaccine effectiveness estimates from case-control studies (2014) (35)
- Assessment of the safety of a third dose of pneumococcal polysaccharide vaccine in the Vaccine Safety Datalink population. (2006) (33)
- Preexisting Immunity, More Than Aging, Influences Influenza Vaccine Responses (2015) (31)
- Improving immunogenicity and effectiveness of influenza vaccine in older adults (2011) (31)
- Reducing the spread of antimicrobial-resistant microorganisms. Control of vancomycin-resistant enterococci. (1995) (29)
- Evaluation of obesity as an independent risk factor for medically attended laboratory‐confirmed influenza (2012) (29)
- Case-Control Study of Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza Hospitalizations in Older Adults, United States, 2010-2011. (2016) (29)
- Respiratory Distress and Sudden Death Associated with Receipt of a Peripheral Parenteral Nutrition Admixture (1997) (28)
- Demographic, socio-economic and geographic determinants of seasonal influenza vaccine uptake in rural western Kenya, 2011. (2014) (25)
- A Pilot Study of Host Genetic Variants Associated with Influenza-associated Deaths among Children and Young Adults (2011) (25)
- Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12–17 Years — United States, December 9, 2021–February 20, 2022 (2022) (25)
- A semiquantitative analysis of the fecal flora of patients with vancomycin-resistant enterococci: colonized patients pose an infection control risk. (1997) (25)
- Effectiveness of 1 dose of influenza A (H1N1) 2009 monovalent vaccines in preventing reverse-transcription polymerase chain reaction-confirmed H1N1 infection among school-aged children in maine. (2012) (24)
- Effectiveness of monovalent 2009 pandemic influenza A virus subtype H1N1 and 2010-2011 trivalent inactivated influenza vaccines in Wisconsin during the 2010-2011 influenza season. (2013) (24)
- Incidence of influenza‐associated mortality and hospitalizations in Argentina during 2002–2009 (2012) (24)
- Influenza-associated excess mortality in southern Brazil, 1980–2008 (2012) (24)
- Comparison of influenza vaccine effectiveness using different methods of case detection: clinician-ordered rapid antigen tests vs. active surveillance and testing with real-time reverse-transcriptase polymerase chain reaction (rRT-PCR). (2011) (23)
- Estimating age‐specific influenza‐related hospitalization rates during the pandemic (H1N1) 2009 in Davidson Co, TN (2012) (23)
- Time-series analyses of count data to estimate the burden of seasonal infectious diseases. (2012) (22)
- Effects of immunizing school children with 2009 influenza A (H1N1) monovalent vaccine on absenteeism among students and teachers in Maine. (2012) (21)
- Inactivated Influenza Vaccines for Prevention of Community-Acquired Pneumonia: The Limits of Using Nonspecific Outcomes in Vaccine Effectiveness Studies (2013) (20)
- High-dose influenza vaccine favors acute plasmablast responses rather than long-term cellular responses. (2016) (20)
- The Pregnancy and Influenza Project: design of an observational case-cohort study to evaluate influenza burden and vaccine effectiveness among pregnant women and their infants. (2011) (19)
- Safety of COVID-19 Vaccination in US Children Ages 5-11 Years. (2022) (19)
- Influenza Pneumonia Surveillance among Hospitalized Adults May Underestimate the Burden of Severe Influenza Disease (2014) (19)
- Severe influenza among children and young adults with neurologic and neurodevelopmental conditions - Ohio, 2011. (2012) (19)
- Use of rapid tests and antiviral medications for influenza among primary care providers in the United States (2009) (18)
- Risk of adverse events following oseltamivir treatment in influenza outpatients, Vaccine Safety Datalink Project, 2007–2010 (2013) (18)
- Incidence and viral aetiologies of acute respiratory illnesses (ARIs) in the United States: a population-based study (2016) (18)
- Oseltamivir Prescribing in Pharmacy-Benefits Database, United States, 2004–2005 (2008) (17)
- Influenza vaccination status is not associated with influenza testing among children: implications for observational studies of vaccine effectiveness. (2011) (17)
- Diagnostic performance of the BinaxNow Influenza A&B rapid antigen test in ED patients. (2012) (17)
- Influence of pre-existing hemagglutination inhibition titers against historical influenza strains on antibody response to inactivated trivalent influenza vaccine in adults 50–80 years of age (2014) (17)
- Household economic impact and attitudes toward school closures in two cities in Argentina during the 2009 influenza A (H1N1) pandemic (2012) (17)
- Trends in mortality from respiratory disease in Latin America since 1998 and the impact of the 2009 influenza pandemic. (2013) (16)
- Prevention and control of influenza. (1986) (16)
- Clinical Characteristics and 30-Day Outcomes for Influenza A 2009 ( H 1 N 1 ) , 2008-2009 ( H 1 N 1 ) , and 2007-2008 ( H 3 N 2 ) Infections (2010) (16)
- Influenza vaccination among the elderly in the United States. (2005) (15)
- Child, Household, and Caregiver Characteristics Associated with Hospitalization for Influenza Among Children 6–59 Months of Age (2014) (15)
- Effectiveness of Nonadjuvanted Monovalent Influenza A(H1N1)pdm09 Vaccines for Preventing Reverse Transcription Polymerase Chain Reaction–Confirmed Pandemic Influenza Hospitalizations: Case-Control Study of Children and Adults at 10 US Influenza Surveillance Network Sites (2013) (14)
- Outcomes at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults in the USA: a follow-up surveillance study (2022) (14)
- Influenza vaccine for community-acquired pneumonia (2008) (14)
- Seasonal Influenza Vaccination of Children Induces Humoral and Cell-Mediated Immunity Beyond the Current Season: Cross-reactivity With Past and Future Strains. (2016) (14)
- Prevention and Control of Seasonal Influenza with Vaccines Recommendations of the Advisory Committee on Immunization Practices ( ACIP ) , 2009 department of health and human services Centers for Disease Control and Prevention (2009) (14)
- COVID-19 mRNA Vaccine Safety Among Children Aged 6 Months–5 Years — United States, June 18, 2022–August 21, 2022 (2022) (14)
- Adamantane-Resistant Influenza Infection During the 2004–05 Season (2008) (14)
- Age, serum 25-hydroxyvitamin D and vitamin D receptor (VDR) expression and function in peripheral blood mononuclear cells (2016) (13)
- Patterns in influenza antiviral medication use before and during the 2009 H1N1 pandemic, Vaccine Safety Datalink Project, 2000–2010 (2012) (13)
- Statin Use and Risks of Influenza-Related Outcomes Among Older Adults Receiving Standard-Dose or High-Dose Influenza Vaccines Through Medicare During 2010–2015 (2018) (12)
- Vitamin E, vitamin A, and zinc status are not related to serologic response to influenza vaccine in older adults: an observational prospective cohort study. (2014) (12)
- Subjective social status predicts wintertime febrile acute respiratory illness among women healthcare personnel. (2014) (12)
- Emergency Department Visits for Influenza A(H1N1)pdm09, Davidson County, Tennessee, USA (2012) (12)
- A randomized intervention trial of mask use and hand hygiene to reduce seasonal influenza-like illness and influenza infections among young adults in a university setting (2010) (11)
- Safety Monitoring of COVID-19 mRNA Vaccine Second Booster Doses Among Adults Aged ≥50 Years — United States, March 29, 2022–July 10, 2022 (2022) (11)
- Reactogenicity within 2 weeks after mRNA COVID-19 vaccines: Findings from the CDC v-safe surveillance system (2021) (11)
- Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Persons Aged ≥12 Years — United States, August 31–October 23, 2022 (2022) (10)
- Case Series of Thrombosis with Thrombocytopenia Syndrome following COVID-19 vaccination--United States, December 2020-August 2021 (2021) (9)
- Estimates of the impact of a future influenza pandemic in China (2009) (9)
- Myocarditis Cases After mRNA-Based COVID-19 Vaccination in the US-Reply. (2022) (9)
- Influenza vaccination for elderly people and their care workers (2006) (8)
- Patterns of seasonal influenza activity in U.S. core-based statistical areas, described using prescriptions of oseltamivir in Medicare claims data (2018) (8)
- Does Google Influenza Tracking Correlate With Laboratory Tests Positive For Influenza (2010) (8)
- Is household antibiotic use a risk factor for antibiotic-resistant pneumococcal infection? (2002) (8)
- A national survey of the Infectious Diseases Society of America Emerging Infections Network concerning neuraminidase inhibitor prescription practices and pandemic influenza preparations. (2006) (8)
- Safety Monitoring of Pfizer-BioNTech COVID-19 Vaccine Booster Doses Among Children Aged 5–11 Years — United States, May 17–July 31, 2022 (2022) (8)
- Reactogenicity of Simultaneous COVID-19 mRNA Booster and Influenza Vaccination in the US (2022) (7)
- Estimated rates of influenza‐associated outpatient visits during 2001‐2010 in 6 US integrated healthcare delivery organizations (2018) (7)
- Evaluating oseltamivir prescriptions in Centers for Medicare and Medicaid Services medical claims records as an indicator of seasonal influenza in the United States (2018) (7)
- Can We “Hedge” against the Development of Antiviral Resistance among Pandemic Influenza Viruses? (2009) (7)
- Variation in hepatitis B immunization coverage rates associated with provider practices after the temporary suspension of the birth dose (2006) (6)
- Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5–11 Years — United States, October 12–January 1, 2023 (2023) (6)
- Validation of a screening instrument to identify persons for exclusion from smallpox vaccination. (2005) (6)
- Expected Rates of Select Adverse Events following Immunization for COVID-19 Vaccine Safety Monitoring (2021) (5)
- Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years with Presumed Immunocompromise Status — United States, January 12, 2022–March 28, 2022 (2022) (5)
- Corrections. Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis. (2015) (5)
- Menstrual irregularities and vaginal bleeding after COVID-19 vaccination reported to v-safe active surveillance, USA in December, 2020–January, 2022: an observational cohort study (2022) (5)
- Alternative models for estimating influenza-attributable P&I deaths in the US (2001) (5)
- School‐Based Influenza Vaccination: Health and Economic Impact of Maine's 2009 Influenza Vaccination Program (2017) (5)
- Can the rolling cross-sectional survey design be used to estimate the effectiveness of influenza vaccines? (2014) (4)
- Studies needed to address public health challenges of the 2009 H1N1 influenza pandemic: insights from modeling (2009) (4)
- Impact of diabetes status on immunogenicity of trivalent inactivated influenza vaccine in older adults (2021) (3)
- Age-Specific Influenza-Related Emergency Department Visits and Hospitalizations in 2010–2011 Compared With the Pandemic Year 2009–2010 (2014) (3)
- Age-specific estimates of US influenza-associated deaths and hospitalizations (2004) (3)
- Reports of Guillain-Barré Syndrome After COVID-19 Vaccination in the United States (2023) (3)
- mpact of influenza on the rates of respiratory disease hospitalizations among young children (2000) (3)
- Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children. Commentary (2006) (2)
- Early discharge of newborns [4] (multiple letters) (1997) (2)
- Safety Monitoring of mRNA Vaccines Administered During the Initial 6 Months of the U.S. COVID-19 Vaccination Program: Reports to Vaccine Adverse Events Reporting System (VAERS) and v-safe (2021) (2)
- Association between history of SARS-CoV-2 infection and severe systemic adverse events after mRNA COVID-19 vaccination among U.S. adults (2022) (2)
- Comment and update on influenza prevention and treatment. (2007) (2)
- Risk Factors For Mortality In Children Admitted To The ICU With Influenza Infection (2010) (1)
- Multiple vaccinations and the risk of medically attended fever. (2010) (1)
- Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices ( ACIP ) , 2008 department of health and human services Centers for Disease Control and Prevention (2008) (1)
- Shift Shown in Influenza A Adamantane Resistance—Reply (2006) (1)
- Influenza vaccination rates and hospitalizations among Medicaid enrollees with and without sickle cell disease, 2009–2015 (2021) (1)
- Vitamin D, influenza vaccine response, and respiratory illness (2012) (1)
- COVID-19 Vaccine Safety First Year Findings in Adolescents. (2023) (1)
- Age An Emerging Infections Program Study (2014) (1)
- Use of High-Dose Influenza and Live Attenuated Influenza Vaccines by US Primary Care Physicians (2021) (1)
- BMI is not a risk factor for medically attended influenza (2011) (0)
- EARLY DISCHARGE OF NEWBORNS. AUTHORS' REPLIES (1997) (0)
- Vitamin D Binding Protein Gene Polymorphisms Are Associated With Clinical Outcomes In Children And Young Adults With Life-Threatening Influenza (2011) (0)
- Hospitalization trends for pneumonia among older persons. Author's reply (2006) (0)
- Estimating Influenza Vaccination Status Among Medicare Beneficiaries: Comparison of Billing Claims and Vaccination Data Obtained from Medical Records and Self-report (2017) (0)
- Shift shown in influenza a Adamantane resistance. Authors' reply (2006) (0)
- Comparing Severity and Outcomes for Seasonal and 2009 H1N1 Infections—Reply (2011) (0)
- Early Discharge of Newborns-Reply (1997) (0)
- The Effectiveness of Influenza Vaccine in Preventing Laboratory-confirmed Influenza Hospitalizations among Children Aged 6-23 Months (2008) (0)
- The Safety of Newborn Early Discharge: The Washington State Experience (1998) (0)
- Effectiveness of Influenza Vaccine in Preventing Death among Ontario Residents Aged ≥65 Years during 20 Seasons (2017) (0)
- Immunoglobulins and Risk of Autism Prenatal and Infant Exposure to Thimerosal From Vaccines and (2012) (0)
- Prevention and Control of Seasonal Influenza with Vaccines Recommendations of the Advisory Committee on Immunization Practices ( ACIP ) , 2009 Prepared by (2009) (0)
- Rapid Assessment of the Effectiveness of Trivalent Inactivated Influenza Vaccine in Wisconsin (2006) (0)
- Hospitalization Trends for Pneumonia Among Older Persons—Reply (2006) (0)
- Morbidity and Mortality Weekly Report (2003) (0)
- The v-safe after vaccination health checker: Active vaccine safety monitoring during CDC’s COVID-19 pandemic response (2023) (0)
- Vitamin D Deficiency Is Associated With Mortality In Patients Admitted To The Pediatric Intensive Care Unit With Community-Acquired Influenza Infection (2010) (0)
- Reply to Fedson. (2014) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With David K. Shay?
David K. Shay is affiliated with the following schools:
